An accelerated hypofractionated radiotherapy regimen in patients after organ-sparing surgery for stages I–IIA breast cancer
Objective: to assess the results of accelerated hypofractionated radiotherapy and to comparatively analyze it with the standard radiotherapy in patients with stages I–IIA breast cancer (BC) after organ-sparing surgery.Materials and methods. A total of 203 patients with stages I–IIA BC underwent radi...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2016-11-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/503 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839570949823791104 |
|---|---|
| author | I. A. Gladilina L. Ya. Klepper Yu. V. Efimkina I. V. Vysotskaya A. V. Petrovskiy O. V. Kozlov M. V. Chernykh E. Yu. Voronchikhina E. S. Makarov A. V. Ivanova |
| author_facet | I. A. Gladilina L. Ya. Klepper Yu. V. Efimkina I. V. Vysotskaya A. V. Petrovskiy O. V. Kozlov M. V. Chernykh E. Yu. Voronchikhina E. S. Makarov A. V. Ivanova |
| author_sort | I. A. Gladilina |
| collection | DOAJ |
| description | Objective: to assess the results of accelerated hypofractionated radiotherapy and to comparatively analyze it with the standard radiotherapy in patients with stages I–IIA breast cancer (BC) after organ-sparing surgery.Materials and methods. A total of 203 patients with stages I–IIA BC underwent radiotherapy after organ-sparing surgery. A control group of 91 patients received the standard radiotherapy (the single focal dose (SFD) was 2 Gy 5 times a week, 25 fractions; the total focal dose (TFD) was 50 Gy for 5 weeks). A study group of 112 patients had accelerated hypofractionated radiotherapy (SFD 3 Gy 5 times a week, 13 fractions; TFD 39 Gy for 2.3 weeks).Results. Local recurrences were not detected in any patient after the hypofractionated radiotherapy regimen and were diagnosed in 3.3 % of the patients after the standard regimen. There were no statistically significant differences between the groups in 5-year overall and relapsefree survival rates. Further observation revealed a statistically significant difference in 6-year overall survival rates in the study and control groups: 99.1 and 70.4 %, respectively (p ≤ 0.046). The 6-year relapse-free survival rates in patients who had received the accelerated hypo-fractionated radiotherapy regimen were also significantly higher than in those who had the standard radiotherapy regimen: 97.9 and 71.3 %, respectively (p ≤ 0.043). The rate of post-radiation normal tissue damages after the hypofractionated radiotherapy regimen was significantly lower (15.2 %) than that after the standard regimen (27.5 %). Good and excellent cosmetic results of treatment were achieved in most (95.1 %) patients and did not differ in their frequency after different radiotherapy regimens.Conclusion. The accelerated hypofractionated radiotherapy regimen showed a high efficiency and a favorable toxicity profile in patients with stages I–IIA BC. |
| format | Article |
| id | doaj-art-de7f30b66d2b4a7c8c192d0cf95959f1 |
| institution | Matheson Library |
| issn | 1994-4098 1999-8627 |
| language | Russian |
| publishDate | 2016-11-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Опухоли женской репродуктивной системы |
| spelling | doaj-art-de7f30b66d2b4a7c8c192d0cf95959f12025-08-04T14:33:40ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272016-11-01123172210.17650/1994-4098-2016-12-3-17-22505An accelerated hypofractionated radiotherapy regimen in patients after organ-sparing surgery for stages I–IIA breast cancerI. A. Gladilina0L. Ya. Klepper1Yu. V. Efimkina2I. V. Vysotskaya3A. V. Petrovskiy4O. V. Kozlov5M. V. Chernykh6E. Yu. Voronchikhina7E. S. Makarov8A. V. Ivanova9N.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaCentral Economics and Mathematics Institute, Russian Academy of SciencesN.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaI.M. Sechenov First Moscow State Medical University, Ministry of Health of RussiaN.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaN.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaN.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaI.M. Sechenov First Moscow State Medical University, Ministry of Health of RussiaN.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaN.N. Blokhin Russian Cancer Research Center, Ministry of Health of RussiaObjective: to assess the results of accelerated hypofractionated radiotherapy and to comparatively analyze it with the standard radiotherapy in patients with stages I–IIA breast cancer (BC) after organ-sparing surgery.Materials and methods. A total of 203 patients with stages I–IIA BC underwent radiotherapy after organ-sparing surgery. A control group of 91 patients received the standard radiotherapy (the single focal dose (SFD) was 2 Gy 5 times a week, 25 fractions; the total focal dose (TFD) was 50 Gy for 5 weeks). A study group of 112 patients had accelerated hypofractionated radiotherapy (SFD 3 Gy 5 times a week, 13 fractions; TFD 39 Gy for 2.3 weeks).Results. Local recurrences were not detected in any patient after the hypofractionated radiotherapy regimen and were diagnosed in 3.3 % of the patients after the standard regimen. There were no statistically significant differences between the groups in 5-year overall and relapsefree survival rates. Further observation revealed a statistically significant difference in 6-year overall survival rates in the study and control groups: 99.1 and 70.4 %, respectively (p ≤ 0.046). The 6-year relapse-free survival rates in patients who had received the accelerated hypo-fractionated radiotherapy regimen were also significantly higher than in those who had the standard radiotherapy regimen: 97.9 and 71.3 %, respectively (p ≤ 0.043). The rate of post-radiation normal tissue damages after the hypofractionated radiotherapy regimen was significantly lower (15.2 %) than that after the standard regimen (27.5 %). Good and excellent cosmetic results of treatment were achieved in most (95.1 %) patients and did not differ in their frequency after different radiotherapy regimens.Conclusion. The accelerated hypofractionated radiotherapy regimen showed a high efficiency and a favorable toxicity profile in patients with stages I–IIA BC.https://ojrs.abvpress.ru/ojrs/article/view/503breast cancerradiotherapyorgan-sparing surgerylocal recurrences |
| spellingShingle | I. A. Gladilina L. Ya. Klepper Yu. V. Efimkina I. V. Vysotskaya A. V. Petrovskiy O. V. Kozlov M. V. Chernykh E. Yu. Voronchikhina E. S. Makarov A. V. Ivanova An accelerated hypofractionated radiotherapy regimen in patients after organ-sparing surgery for stages I–IIA breast cancer Опухоли женской репродуктивной системы breast cancer radiotherapy organ-sparing surgery local recurrences |
| title | An accelerated hypofractionated radiotherapy regimen in patients after organ-sparing surgery for stages I–IIA breast cancer |
| title_full | An accelerated hypofractionated radiotherapy regimen in patients after organ-sparing surgery for stages I–IIA breast cancer |
| title_fullStr | An accelerated hypofractionated radiotherapy regimen in patients after organ-sparing surgery for stages I–IIA breast cancer |
| title_full_unstemmed | An accelerated hypofractionated radiotherapy regimen in patients after organ-sparing surgery for stages I–IIA breast cancer |
| title_short | An accelerated hypofractionated radiotherapy regimen in patients after organ-sparing surgery for stages I–IIA breast cancer |
| title_sort | accelerated hypofractionated radiotherapy regimen in patients after organ sparing surgery for stages i iia breast cancer |
| topic | breast cancer radiotherapy organ-sparing surgery local recurrences |
| url | https://ojrs.abvpress.ru/ojrs/article/view/503 |
| work_keys_str_mv | AT iagladilina anacceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT lyaklepper anacceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT yuvefimkina anacceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT ivvysotskaya anacceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT avpetrovskiy anacceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT ovkozlov anacceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT mvchernykh anacceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT eyuvoronchikhina anacceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT esmakarov anacceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT avivanova anacceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT iagladilina acceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT lyaklepper acceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT yuvefimkina acceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT ivvysotskaya acceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT avpetrovskiy acceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT ovkozlov acceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT mvchernykh acceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT eyuvoronchikhina acceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT esmakarov acceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer AT avivanova acceleratedhypofractionatedradiotherapyregimeninpatientsafterorgansparingsurgeryforstagesiiiabreastcancer |